ISPOR - Amnog Dossiers As A Challenge for Pharmaceutical Companies- Is There A Correlation Between Volumes and Added Medical Benefit?

Full Text

Amnog Dossiers As A Challenge for Pharmaceutical Companies- Is There A Correlation Between Volumes and Added Medical Benefit?

Abstract

Authors

W Kulp MT Reinartz

Back to Volume 20, Issue 9

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now